Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dihydroartemisinin Tablets for the Treatment of Discoid Lupus Erythematosus
NCT07557927Phase 2Not yet recruiting
- Start
- Apr 2026
- Primary completion
- Sep 2028
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dihydroartemisinin in discoid lupus erythematosus (DLE). Planned start Apr 2026; status: not yet recruiting.
02
Drugs
dihydroartemisinin
03
Conditions
discoid lupus erythematosus (DLE)
Beyond the preview
Go deeper on NCT07557927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07557927.